These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38970559)

  • 41. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
    Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
    López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
    Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F
    J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
    Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
    Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating microRNA Expression in Cushing's Syndrome.
    Vetrivel S; Zhang R; Engel M; Altieri B; Braun L; Osswald A; Bidlingmaier M; Fassnacht M; Beuschlein F; Reincke M; Chen A; Sbiera S; Riester A
    Front Endocrinol (Lausanne); 2021; 12():620012. PubMed ID: 33692756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.
    Cunningham JM; Buxton OM; Weiss RE
    J Endocrinol Invest; 2002 Oct; 25(9):791-9. PubMed ID: 12398238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
    Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic
    Detomas M; Altieri B; Schlötelburg W; Appenzeller S; Schlaffer S; Coras R; Schirbel A; Wild V; Kroiss M; Sbiera S; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2021; 12():731579. PubMed ID: 34489873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases.
    Kuhn JM; Proeschel MF; Seurin DJ; Bertagna XY; Luton JP; Girard FL
    Am J Med; 1989 Jun; 86(6 Pt 1):678-84. PubMed ID: 2543219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening for Cushing's syndrome in obese patients.
    Tiryakioglu O; Ugurlu S; Yalin S; Yirmibescik S; Caglar E; Yetkin DO; Kadioglu P
    Clinics (Sao Paulo); 2010; 65(1):9-13. PubMed ID: 20126340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mifepristone: treatment of Cushing's syndrome.
    Sartor O; Cutler GB
    Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathophysiology and diagnosis of Cushing's syndrome.
    Miyachi Y
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():113s-117s. PubMed ID: 10915006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
    Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
    Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing's syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing's syndrome.
    Reibetanz J; Kelm M; Uttinger KL; Reuter M; Schlegel N; Hankir M; Wiegering V; Germer CT; Fassnacht M; Lock JF; Wiegering A
    Langenbecks Arch Surg; 2022 Sep; 407(6):2481-2488. PubMed ID: 35633419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.